HWGB BIOTECH ENTERS INTO COVID-19 VACCINE R&D AGREEMENTS
KUALA LUMPUR, Sept 18 -- HWGB Biotech Sdn Bhd’s joint venture partner, US-based E-MO Biology Inc (EBI), has entered into three research and development (R&D) agreements to produce COVID-19 vaccines.
EBI’s contracts are with Dr John Andrews through Black Diamond Networks (professional service agreement), Roderick A. Comunale II MD Inc, and America Diagnostic & Genescan Diagnostics Inc.
HWGB Biotech chief executive officer Datuk Aaron Lim said the agreements would bring in expertise that will help boost clinical trials in accordance with US laws.
“We look forward to the fruitful work that will come from the collaborations with our partners.
“Time is important in the production of the vaccine given how the pandemic has ravaged Southeast Asia’s population and its economies,” he said in a statement.
HWGB Biotech is a wholly-owned subsidiary of Ho Wah Genting Bhd while EBI, incorporated in California, US is principally involved in conducting biology R&D and is the sponsor of a study which indicates booster polio vaccine to reduce COVID-19 SARS-COV-2 infection and severity.
-- BERNAMA
BERNAMA provides up-to-date authentic and comprehensive news and information which are disseminated via BERNAMA Wires; www.bernama.com; BERNAMA TV on Astro 502, unifi TV 631 and MYTV 121 IFLIX channels and BERNAMA Radio on FM93.9 (Klang Valley), FM107.5 (Johor Bahru), FM107.9 (Kota Kinabalu) and FM100.9 (Kuching) frequencies.
Follow us on social media :
Facebook : @bernamaofficial, @bernamatv, @bernamaradio
Twitter : @bernama.com, @BernamaTV, @bernamaradio
Instagram : @bernamaofficial, @bernamatvofficial, @bernamaradioofficial
TikTok : @bernamaofficial
